07:52 AM EST, 11/12/2024 (MT Newswires) -- Axsome Therapeutics ( AXSM ) reported a Q3 loss Tuesday of $1.34 per share, widening from a loss of $1.32 a year earlier.

Analysts polled by Capital IQ expected a loss of $1.41.

Revenue for the quarter ended Sept. 30 was $104.8 million, up from $57.8 million a year earlier.

Analysts surveyed by Capital IQ expected $98.1 million.

Shares of the company were up more than 1% in premarket activity Tuesday.

Price: 92.01, Change: +1.03, Percent Change: +1.13